Target intelligence / Profile preview

Fragment crystallizable region of immunoglobulin (Fc fragment (or Fc region))

Target
Fc fragment (or Fc region)
Molecular classification
Other, Glycoprotein domain
01

Overview

The Fc fragment (Fragment crystallizable region) is the constant portion of an antibody produced by proteolytic cleavage, distinct from the antigen-binding Fab regions. It consists primarily of the C-terminal constant domains (CH2, CH3, sometimes CH4 for IgM/IgE) of the heavy chains. The Fc fragment is crucial for immune effector activity: it binds to Fc receptors expressed on various immune cells (including macrophages, NK cells, neutrophils), and to components of the complement system, mediating cell lysis, phagocytosis, degranulation, and clearance of opsonized targets. Fc glycosylation is critical for these functions. While not a standalone therapeutic target, engineering the Fc region is central to therapeutic antibody development, regulating their efficacy, serum half-life, and immune activation.

Other names
Fc regionFragment crystallizable regionImmunoglobulin FcFc tail
02

Mechanism of action

Mediates antibody-dependent cellular cytotoxicity (ADCC) via Fcγ receptor binding; Mediates antibody-dependent cellular phagocytosis (ADCP); Activates complement-dependent cytotoxicity (CDC) via complement protein binding; Modulates serum half-life via neonatal Fc receptor (FcRn) interaction.

03

Biological functions

Immune effector function mediationBinding to Fc receptors on immune cellsBinding to complement proteinsTriggering cell lysis, opsonization, degranulationIncreasing antibody serum half-life (via binding to FcRn)
04

Disease associations

Cancer (as part of therapeutic monoclonal antibodies/antibody-drug conjugates)Autoimmune diseases (antibody therapies, engineered Fc for reduced effector functions)Inflammatory disease (modulating antibody effector function)Infection (antibody-based therapies that harness Fc-mediated clearance)Other (plays a role wherever antibody effector function is relevant—through engineered therapeutic antibodies)
05

Safety considerations

Immunogenicity of engineered Fc domainsOff-target immune activation (enhanced Fc effector functions may lead to unwanted cell/tissue damage)Altered pharmacokinetics/clearance when Fc is heavily modified
06

Interacting drugs

None directly, but many therapeutic monoclonal antibodies have engineered Fc regions (e.g., rituximab, adalimumab, trastuzumab). Fc fusion proteins also include drugs like etanercept.
07

Biomarkers

Fc glycosylation pattern (used to monitor antibody function/efficacy)Presence/level of therapeutic monoclonal antibody (when monitoring antibody drugs incorporating Fc region)

Beyond the preview

Go deeper on Fragment crystallizable region of immunoglobulin (Fc fragment (or Fc region)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fragment crystallizable region of immunoglobulin (Fc fragment (or Fc region)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call